Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

COX-2 [cyclooxygenase-2] regulation of renal sodium handling in blood pressure maintenance.

Trial Profile

COX-2 [cyclooxygenase-2] regulation of renal sodium handling in blood pressure maintenance.

Phase of Trial: Phase IV

Latest Information Update: 18 Jul 2013

At a glance

  • Drugs Celecoxib (Primary)
  • Indications Acute pain; Ankylosing spondylitis; Back pain; Cervicobrachial syndrome; Dysmenorrhoea; Gouty arthritis; Juvenile rheumatoid arthritis; Osteoarthritis; Pain; Periarthritis; Postoperative pain; Rheumatic disorders; Rheumatoid arthritis; Tenosynovitis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 20 Dec 2011 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
    • 20 Dec 2011 Actual patient number is 12 according to ClinicalTrials.gov.
    • 20 Dec 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top